TRUALTBSETrualt Bioenergy LtdMediumNeutral
Announced Thu, 28 May · 16:20 IST

Transcript of earning conference call held on May 22, 2026 at 05:00 PM on the audited financial results for the quarter and year ended March 31, 2026.

Mgmt Guided Margin ImprovementOrder Pipeline DisclosedAnalyst Day Multiyear TargetsMgmt Evaded Key QuestionInvestor Communications View source PDF

TRUALT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹493.00
prior close
₹497.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2+1.9+2.4+3.4+0.5+3.2+1.6+2.4+2.8+8.0-0.6-7.1
Up moveDown movePending
AI summary

TruAlt Bioenergy reported FY26 standalone revenue of INR1,704 crores (down 9.4% YoY) due to unfavorable ethanol allocation methodology by OMCs. The company received only 26 crore litres against a bid of 72 crore litres (34% allocation). EBITDA margin improved from 18.98% to 19.81%, but PBT declined to INR109.47 crores (from INR152.15 crores) due to higher depreciation (+30%) and finance costs (+11.92%) from recent capex capitalization. The company has pending court order for additional 15 crore litres allocation from Karnataka High Court. Currently operating at only 35% capacity utilization. Management is diversifying into CBG (expanding to 162 TPD from 10 TPD), Sustainable Aviation Fuel (10 crore litre plant with Honeywell UOP), and fuel retail (7 outlets operational, targeting 87).

Likely market impact

Revenue declined due to ethanol allocation issues, but EBITDA margin improvement shows cost control. Pending court order and new business verticals (CBG, SAF, retail) provide growth visibility. High leverage from capex impacts near-term profitability.